de State Street TG Therapeutics TGTX Historial de posiciones en acciones
Compró
Mantenido
Vendió
| Trimestre | Valor de mercado | Estado | Núm. de acciones |
Cambio en la participación | Valor operado | Peso en el portafolio | Posición de la cartera | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | USD 428 M | Vender |
7,786,471
-863,295
| -10% | -USD 35.3 M | 0.01% | 657 |
|
|
2026
Q1 | USD 287 M | Comprar |
8,649,766
+169,767
| +2% | +USD 5.06 M | 0.01% | 773 |
|
|
2025
Q4 | USD 253 M | Comprar |
8,479,999
+379,380
| +5% | +USD 12.4 M | 0.01% | 820 |
|
|
2025
Q3 | USD 293 M | Comprar |
8,100,619
+482,381
| +6% | +USD 15.9 M | 0.01% | 750 |
|
|
2025
Q2 | USD 274 M | Comprar |
7,618,238
+184,339
| +2% | +USD 6.86 M | 0.01% | 745 |
|
|
2025
Q1 | USD 293 M | Vender |
7,433,899
-1,766,009
| -19% | -USD 59.4 M | 0.01% | 697 |
|
|
2024
Q4 | USD 277 M | Comprar |
9,199,908
+105,750
| +1% | +USD 3.03 M | 0.01% | 750 |
|
|
2024
Q3 | USD 213 M | Comprar |
9,094,158
+2,398,015
| +36% | +USD 52.4 M | 0.01% | 888 |
|
|
2024
Q2 | USD 119 M | Vender |
6,696,143
-1,100,436
| -14% | -USD 17.6 M | 0.01% | 1160 |
|
|
2024
Q1 | USD 119 M | Vender |
7,796,579
-456,994
| -6% | -USD 7.28 M | 0.01% | 1199 |
|
|
2023
Q4 | USD 141 M | Vender |
8,253,573
-1,564,049
| -16% | -USD 18.2 M | 0.01% | 1066 |
|
|
2023
Q3 | USD 82.1 M | Comprar |
9,817,622
+4,189,436
| +74% | +USD 58.4 M | ﹤0.01% | 1312 |
|
|
2023
Q2 | USD 140 M | Vender |
5,628,186
-2,015,619
| -26% | -USD 52.1 M | 0.01% | 1008 |
|
|
2023
Q1 | USD 115 M | Vender |
7,643,805
-2,771,356
| -27% | -USD 42.1 M | 0.01% | 1089 |
|
|
2022
Q4 | USD 123 M | Vender |
10,415,161
-1,335,239
| -11% | -USD 9.7 M | 0.01% | 1043 |
|
|
2022
Q3 | USD 69.6 M | Vender |
11,750,400
-2,484,863
| -17% | -USD 16.3 M | ﹤0.01% | 1362 |
|
|
2022
Q2 | USD 60.5 M | Comprar |
14,235,263
+4,606,679
| +48% | +USD 28.8 M | ﹤0.01% | 1502 |
|
|
2022
Q1 | USD 91.6 M | Comprar |
9,628,584
+3,804,406
| +65% | +USD 44 M | ﹤0.01% | 1352 |
|
|
2021
Q4 | USD 111 M | Comprar |
5,824,178
+1,527,426
| +36% | +USD 39.7 M | 0.01% | 1226 |
|
|
2021
Q3 | USD 143 M | Comprar |
4,296,752
+684,605
| +19% | +USD 21.2 M | 0.01% | 1022 |
|
|
2021
Q2 | USD 140 M | Comprar |
3,612,147
+352,866
| +11% | +USD 13.9 M | 0.01% | 1055 |
|
|
2021
Q1 | USD 157 M | Vender |
3,259,281
-453,561
| -12% | -USD 21.8 M | 0.01% | 912 |
|
|
2020
Q4 | USD 193 M | Vender |
3,712,842
-396,277
| -10% | -USD 13.4 M | 0.01% | 761 |
|
|
2020
Q3 | USD 110 M | Vender |
4,109,119
-918,008
| -18% | -USD 21.1 M | 0.01% | 914 |
|
|
2020
Q2 | USD 97.9 M | Comprar |
5,027,127
+1,532,474
| +44% | +USD 24.7 M | 0.01% | 977 |
|
|
2020
Q1 | USD 34.4 M | Comprar |
3,494,653
+89,348
| +3% | +USD 1.13 M | ﹤0.01% | 1499 |
|
|
2019
Q4 | USD 37.8 M | Vender |
3,405,305
-505,419
| -13% | -USD 3.84 M | ﹤0.01% | 1710 |
|
|
2019
Q3 | USD 22 M | Vender |
3,910,724
-1,319,257
| -25% | -USD 9.2 M | ﹤0.01% | 2005 |
|
|
2019
Q2 | USD 45.2 M | Comprar |
5,229,981
+1,953,015
| +60% | +USD 14.8 M | ﹤0.01% | 1546 |
|
|
2019
Q1 | USD 26.3 M | Vender |
3,276,966
-1,065,652
| -25% | -USD 5.76 M | ﹤0.01% | 1872 |
|
|
2018
Q4 | USD 17.8 M | Comprar |
4,342,618
+206,901
| +5% | +USD 1.03 M | ﹤0.01% | 2071 |
|
|
2018
Q3 | USD 23.2 M | Comprar |
4,135,717
+423,614
| +11% | +USD 4.84 M | ﹤0.01% | 2079 |
|
|
2018
Q2 | USD 48.8 M | Comprar |
3,712,103
+593,842
| +19% | +USD 8.17 M | ﹤0.01% | 1507 |
|
|
2018
Q1 | USD 44.3 M | Vender |
3,118,261
-293,405
| -9% | -USD 3.75 M | ﹤0.01% | 1497 |
|
|
2017
Q4 | USD 28 M | Comprar |
3,411,666
+159,201
| +5% | +USD 1.39 M | ﹤0.01% | 1828 |
|
|
2017
Q3 | USD 38.5 M | Comprar |
3,252,465
+613,782
| +23% | +USD 6.99 M | ﹤0.01% | 1551 |
|
|
2017
Q2 | USD 26.5 M | Comprar |
2,638,683
+1,933,896
| +274% | +USD 21.6 M | ﹤0.01% | 1796 |
|
|
2017
Q1 | USD 8.21 M | Comprar |
704,787
+25,672
| +4% | +USD 184 k | ﹤0.01% | 2462 |
|
|
2016
Q4 | USD 3.16 M | Comprar |
679,115
+42,760
| +7% | +USD 251 k | ﹤0.01% | 2912 |
|
|
2016
Q3 | USD 4.92 M | Comprar |
636,355
+12,048
| +2% | +USD 77.5 k | ﹤0.01% | 2573 |
|
|
2016
Q2 | USD 3.78 M | Vender |
624,307
-556,731
| -47% | -USD 4.53 M | ﹤0.01% | 2763 |
|
|
2016
Q1 | USD 10.1 M | Comprar |
1,181,038
+39,117
| +3% | +USD 342 k | ﹤0.01% | 2169 |
|
|
2015
Q4 | USD 13.6 M | Vender |
1,141,921
-1,493,102
| -57% | -USD 18.9 M | ﹤0.01% | 1999 |
|
|
2015
Q3 | USD 26.6 M | Comprar |
2,635,023
+542,774
| +26% | +USD 8.09 M | ﹤0.01% | 1558 |
|
|
2015
Q2 | USD 34.7 M | Comprar |
2,092,249
+424,565
| +25% | +USD 6.72 M | ﹤0.01% | 1483 |
|
|
2015
Q1 | USD 25.8 M | Comprar |
1,667,684
+1,311,768
| +369% | +USD 19.9 M | ﹤0.01% | 1668 |
|
|
2014
Q4 | USD 5.64 M | Comprar |
355,916
+84,524
| +31% | +USD 1.1 M | ﹤0.01% | 2504 |
|
|
2014
Q3 | USD 2.9 M | Comprar |
271,392
+48,749
| +22% | +USD 452 k | ﹤0.01% | 2824 |
|
|
2014
Q2 | USD 2.09 M | Comprar |
222,643
+13,656
| +7% | +USD 87.3 k | ﹤0.01% | 3051 |
|
|
2014
Q1 | USD 1.44 M | Comprar |
208,987
+66,433
| +47% | +USD 393 k | ﹤0.01% | 3177 |
|
|
2013
Q4 | USD 558 k | Vender |
142,554
-13,210
| -8% | -USD 53.4 k | ﹤0.01% | 3347 |
|
|
2013
Q3 | USD 793 k | Comprar |
155,764
+97,833
| +169% | +USD 598 k | ﹤0.01% | 3285 |
|
|
2013
Q2 | USD 371 k | Comprar |
+57,931
| Nuevas | +USD 371 k | ﹤0.01% | 3274 |
|
Otros fondos que tienen TGTX en su cartera
Posición de State Street en TGTX: resumen de T2 2026
State Street redujo su participación en TG Therapeutics (TGTX) en 10% durante T2 2026, al vender acciones por un valor estimado de USD 35.3 M, y conservó 7,786,471 acciones valuadas en USD 428 M. La posición representa 0.01% de la cartera y ocupa el puesto #657.
State Street reportó por primera vez una posición en TGTX en T2 2013 y la ha mantenido durante 53 trimestres desde entonces. Al cierre de T2 2026, 434 fondos que sigue Wall St. Rank mantienen una posición en TGTX.
- Al cierre de T2 2026, State Street tenía 7,786,471 acciones de TG Therapeutics con un valor de USD 428 M.
- State Street vendió 863,295 acciones de TG Therapeutics en T2 2026, por un valor estimado de USD 35.3 M.
- TG Therapeutics representó 0.01% de la cartera de State Street en T2 2026 y fue su posición número 657.
- State Street reportó por primera vez una posición en TG Therapeutics en T2 2013 y la ha mantenido durante 53 trimestres desde entonces.
- Al cierre de T2 2026, 434 fondos que sigue Wall St. Rank tenían TG Therapeutics en cartera.
Según el Informe 13F de State Street correspondiente a T2 2026, presentado el 7 ago 2026.